References
- WoodruffPGAgustiARocheNSinghDMartinezFJCurrent concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised managementLancet201538599791789179825943943
- HindsDRDiSantostefanoRLLeHVPascoeSIdentification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysisBMJ Open201666e010099
- PavordIDLettisSLocantoreNBlood eosinophils and inhaled corticosteroid/long-acting beta-2 agonist efficacy in COPDThorax201671211812526585525
- Vedel-KroghSNielsenSFLangePVestboJNordestgaardBGBlood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population StudyAm J Respir Crit Care Med2016193996597426641631
- SiddiquiSHGuasconiAVestboJBlood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015192452352526051430
- PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
- BarnesNCSharmaRLettisSCalverleyPMBlood eosinophils as a marker of response to inhaled corticosteroids in COPDEur Respir J20164751374138226917606
- BafadhelMDaviesLCalverleyPMAaronSDBrightlingCEPavordIDBlood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysisEur Respir J201444378979124925917
- BafadhelMGreeningNJHarvey-DunstanTCBlood eosinophils and outcomes in severe hospitalised exacerbations of COPDChest2016150232032826851799
- WedzichaJABanerjiDChapmanKRIndacaterol-glycopyrronium versus salmeterol-fluticasone for COPDN Engl J Med2016374232222223427181606
- DumanDAksoyEAgcaMCThe utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophiliaInt J Chron Obstruct Pulmon Dis2015102469247826648709
- BurgelPRPaillasseurJLCaillaudDClinical COPD phenotypes: a novel approach using principal component and cluster analysesEur Respir J201036353153920075045
- WatzHTetzlaffKWoutersEFBlood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialLancet Respir Med20164539039827066739
- DiSantostefanoRLHindsDVan LeHBarnesNCRelationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohortRespir Med2016112889626872700
- CaillaudDChanezPEscamillaRAsthma-COPD overlap syndrome (acos) versus “pure” COPD: a distinct phenotype?Allergy201772113714527501862
- SinghDKolsumUBrightlingCEEosinophilic inflammation in COPD: prevalence and clinical characteristicsEur Respir J20144461697170025323230
- KeeneJDJacobsonSKechrisKCOPDGene and SPIROMICS InvestigatorsBiomarkers predictive of exacerbations in the SPIROM-ICS and COPDGene cohortsAm J Respir Crit Care Med2017195447348127579823